Replies to post #837 on RedHill Biopharma Ltd (RDHL)

[Amatuer17]

No - next month we will hear from DSMB (Data Safety monitoring Board) committee about Interim analysis on safety and if there are and changes needed.

If we are lucky - the DSMB will see such efficacy of the drug that they will recommend to stop study early - (this is like dream and low probability)

The overall enrollment is supposed to be over by end of 2017